A phase 1 study of brilaroxazine lipogel in psoriasis patients
Latest Information Update: 21 May 2024
At a glance
- Drugs Brilaroxazine (Primary)
- Indications Psoriasis
- Focus Adverse reactions
Most Recent Events
- 14 May 2024 According to a Reviva Pharmaceuticals media release, Investigational new drug application (IND) submission for liposomal-gel formulation of brilaroxazine in psoriasis expected in 2025.
- 16 May 2023 New trial record
- 11 May 2023 According to a Reviva Pharmaceuticals media release, IND submission for brilaroxazine lipogel in psoriasis expected in 2024.